CD146 as a potent target for anti-vascular therapies in lung cancer brain metastasis

Name: CD146 as a potent target for anti-vascular therapies in lung cancer brain metastasis
Creator: The Second Hospital of Dalian Medical University
Published: 2023-11-30T12:50:47+08:00

integrated proteome resources2026-02-07 收录

肺癌脑转移治疗

血管靶向治疗

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0007663000 数据链接链接失效反馈

官方服务：

资源简介：

CD146 as a potent target for anti-vascular therapies in lung cancer brain metastasis

提供机构：

The Second Hospital of Dalian Medical University

创建时间：

2023-11-30

Chemical Sensors Detect and Resolve Proteome Aggregation in Peripheral Neuropathy induced by Chemotherapeutic Agents

传感器

外周神经病变

Chemical Sensors Detect and Resolve Proteome Aggregation in Peripheral Neuropathy induced by Chemotherapeutic Agents

integrated proteome resources100

Table_1_Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients.docx

肺癌脑转移治疗

EGFR靶向治疗疗效评估

Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is revolutionizing the management of brain metastases (BMs). This study was to explore the value of upfront cranial

NIAID Data Ecosystem20

Table_1_The efficacy of upfront craniocerebral radiotherapy and epidermal growth factor receptor-tyrosine kinase inhibitors in patients with epidermal growth factor receptor-positive non-small cell lung cancer with brain metastases.docx

肺癌脑转移治疗

EGFR-TKI联合放疗疗效评估

The present study aims to investigate the therapeutic value of third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) combined with cranial radiotherapy (RT) in pat

NIAID Data Ecosystem10

Table_2_Upfront Cranial Radiotherapy vs. EGFR Tyrosine Kinase Inhibitors Alone for the Treatment of Brain Metastases From Non-small-cell Lung Cancer: A Meta-Analysis of 1465 Patients.docx

肺癌脑转移治疗

EGFR-TKI联合治疗

Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is revolutionizing the management of brain metastases (BMs). This study was to explore the value of upfront cranial

NIAID Data Ecosystem70

SCLC brain metastasis

肺癌脑转移治疗

神经分化机制

Brain metastasis is a major cause of morbidity and mortality in cancer patients. Here we investigated mechanisms allowing small-cell lung cancer (SCLC) cells to grow in the brain. We show that SCLC ce

NIAID Data Ecosystem20

CD146 as a potent target for anti-vascular therapies in lung cancer brain metastasis

资源简介：

相关数据集